473 related articles for article (PubMed ID: 28476949)
1. Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease.
Royea J; Zhang L; Tong XK; Hamel E
J Neurosci; 2017 May; 37(22):5562-5573. PubMed ID: 28476949
[TBL] [Abstract][Full Text] [Related]
2. AT2R's (Angiotensin II Type 2 Receptor's) Role in Cognitive and Cerebrovascular Deficits in a Mouse Model of Alzheimer Disease.
Royea J; Lacalle-Aurioles M; Trigiani LJ; Fermigier A; Hamel E
Hypertension; 2020 Jun; 75(6):1464-1474. PubMed ID: 32362228
[TBL] [Abstract][Full Text] [Related]
3. Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer's disease.
Royea J; Martinot P; Hamel E
Neurobiol Dis; 2020 Feb; 134():104644. PubMed ID: 31669735
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model.
Ongali B; Nicolakakis N; Tong XK; Aboulkassim T; Papadopoulos P; Rosa-Neto P; Lecrux C; Imboden H; Hamel E
Neurobiol Dis; 2014 Aug; 68():126-36. PubMed ID: 24807206
[TBL] [Abstract][Full Text] [Related]
5. Losartan improves cerebrovascular function in a mouse model of Alzheimer's disease with combined overproduction of amyloid-β and transforming growth factor-β1.
Papadopoulos P; Tong XK; Imboden H; Hamel E
J Cereb Blood Flow Metab; 2017 Jun; 37(6):1959-1970. PubMed ID: 27389178
[TBL] [Abstract][Full Text] [Related]
6. Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.
Ongali B; Nicolakakis N; Tong XK; Aboulkassim T; Imboden H; Hamel E
J Alzheimers Dis; 2016; 51(4):1183-95. PubMed ID: 26923013
[TBL] [Abstract][Full Text] [Related]
7. Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice.
Lacoste B; Tong XK; Lahjouji K; Couture R; Hamel E
J Neuroinflammation; 2013 May; 10():57. PubMed ID: 23642031
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease.
Danielyan L; Klein R; Hanson LR; Buadze M; Schwab M; Gleiter CH; Frey WH
Rejuvenation Res; 2010; 13(2-3):195-201. PubMed ID: 20370487
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology.
Papadopoulos P; Rosa-Neto P; Rochford J; Hamel E
PLoS One; 2013; 8(7):e68612. PubMed ID: 23874687
[TBL] [Abstract][Full Text] [Related]
10. Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.
Hamel E; Royea J; Ongali B; Tong XK
Cell Mol Neurobiol; 2016 Mar; 36(2):219-32. PubMed ID: 26993506
[TBL] [Abstract][Full Text] [Related]
11. Pleiotropic Benefits of the Angiotensin Receptor Blocker Candesartan in a Mouse Model of Alzheimer Disease.
Trigiani LJ; Royea J; Lacalle-Aurioles M; Tong XK; Hamel E
Hypertension; 2018 Nov; 72(5):1217-1226. PubMed ID: 30354809
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's disease.
Ongali B; Nicolakakis N; Lecrux C; Aboulkassim T; Rosa-Neto P; Papadopoulos P; Tong XK; Hamel E
Am J Pathol; 2010 Dec; 177(6):3071-80. PubMed ID: 21088218
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling.
Takeda S; Sato N; Takeuchi D; Kurinami H; Shinohara M; Niisato K; Kano M; Ogihara T; Rakugi H; Morishita R
Hypertension; 2009 Dec; 54(6):1345-52. PubMed ID: 19805638
[TBL] [Abstract][Full Text] [Related]
15. Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets.
Royea J; Hamel E
Geroscience; 2020 Oct; 42(5):1237-1256. PubMed ID: 32700176
[TBL] [Abstract][Full Text] [Related]
16. Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist.
Nicolakakis N; Aboulkassim T; Ongali B; Lecrux C; Fernandes P; Rosa-Neto P; Tong XK; Hamel E
J Neurosci; 2008 Sep; 28(37):9287-96. PubMed ID: 18784309
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits.
Tong XK; Lecrux C; Rosa-Neto P; Hamel E
J Neurosci; 2012 Apr; 32(14):4705-15. PubMed ID: 22492027
[TBL] [Abstract][Full Text] [Related]
18. Memantine improves spatial learning and memory impairments by regulating NGF signaling in APP/PS1 transgenic mice.
Liu MY; Wang S; Yao WF; Zhang ZJ; Zhong X; Sha L; He M; Zheng ZH; Wei MJ
Neuroscience; 2014 Jul; 273():141-51. PubMed ID: 24846616
[TBL] [Abstract][Full Text] [Related]
19. Antroquinonol Lowers Brain Amyloid-β Levels and Improves Spatial Learning and Memory in a Transgenic Mouse Model of Alzheimer's Disease.
Chang WH; Chen MC; Cheng IH
Sci Rep; 2015 Oct; 5():15067. PubMed ID: 26469245
[TBL] [Abstract][Full Text] [Related]
20. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
